Share with a Friend
Personalized medicine helps doctors learn about a person’s genetic makeup and how his or her tumor grows. Modern personalized medicine is based on targeted therapy. In targeted therapy, it is essential that information about the altered pathway and the components leading to cancer are available. During this symposium, physicians will discuss the treatment modalities, prognosis and clinical trials associated with head and neck cancer.
Who Should Attend
This symposium is appropriate to the learning needs of physicians and healthcare professionals
involved in the head and neck cancer patient care team, including:
Primary Care Physicians
Oral Maxillofacial Surgeons
NOTE: Photographs may be taken at this symposium. By participating at our symposium, you consent to photography of your image and likeness for use on our symposium websites, social media pages and press releases distributed for marketing purposes. Should you not agree to photography, please notify us prior to this symposium. Thank you.